TrialClinical drug investigation2025

Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid Arthritis.

Gerd Burmester et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.